<DOC>
	<DOCNO>NCT00438399</DOCNO>
	<brief_summary>The scalp one common affect site psoriatic patient 79 % scalp involvement.It also psychological aspect 31 % patient scalp psoriasis indicate distress . Topical agent remain mainstay treatment scalp psoriasis . However , always ideal might inconvenient messy use , stain damage hair . The test shampoo , Clobetasol propionate Shampoo 0.05 % ( market USA tradename ClobexÂ® ) develop provide strong available corticosteroid short-contact therapy order improve chance effective reduce potential traditional side-effects . The objective study compare subject 's overall preference Clobetasol propionate shampoo 0.05 % three topical corticosteroid treatment moderate severe scalp psoriasis .</brief_summary>
	<brief_title>Subject Preference Scalp Psoriasis Treatment</brief_title>
	<detailed_description>This study multi-centre , investigator blind , randomize , cross-over , intra-individual comparison three parallel group . In parallel group , Clobetasol propionate shampoo , 0.05 % compare one three chosen competitor , follow cross-over design .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>Male female subject , 18 year age old , Subjects moderate severe scalp psoriasis , Subjects sign write informed consent prior study procedure . Subjects need systemic treatment body psoriasis , Subjects risk term precaution , warning contraindication , Female subject pregnant , nurse plan pregnancy study , Subjects specific washout period topical treatment ( ) scalp , Subjects specific washout period systemic treatment ( ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>1 Galderma ,</keyword>
	<keyword>2 Scalp Psoriasis</keyword>
	<keyword>3 Subject preference</keyword>
	<keyword>4 Clobetasol propionate</keyword>
	<keyword>5 Shampoo</keyword>
</DOC>